Table 1.
DKD related non-coding RNA
| non-coding RNA changes | Mediators or Related Pathways | Effects | Reference(s) |
|---|---|---|---|
| miR-15b-5p upregulation | Targeting BCL-2 | Promoting DKD progression and deterioration of renal function | 96 |
| miR-216a-5p upregulation | Inhibiting MAPK pathway | Promoting MC apoptosis | 97 |
| MiR-21 upregulation | Activating the TGF-β1/Smad3 pathway | Promoting MC hypertrophy | 101, 102 |
| miR-29 downregulation | Targeting ECM components | Promoting collagen expression and kidney fibrosis | 103 |
| LncRNA SOX2OT downregulation | Activating Akt/mTOR pathway | Promoting MC proliferation, and fibrosis gene expression | 107 |
| LncRNA DANCR downregulation | Inhibiting TGF-β/Smad signaling | Inducing extracellular matrix accumulation in HMCs | 108 |
| lncRNA MIAT upregulation | Modulating the miR-147a/E2F3 axis | Inducing mesangial cell proliferation and fibrosis | 109 |
| lncRNA XIST upregulation | Inhibiting miR-423-5p | Increasing MC proliferation in DKD | 110 |
| lncRNA SNHG14 upregulation | Inhibiting miR-424-5p | Promoting mesangial cell proliferation and ECM accumulation | 111 |
| LINC01232 upregulation | Attenuating miR-1250-3p | Attenuating MCs proliferation and fibrosis in DKD | 112 |
| CircRNA DLGAP4 upregulation | Inhibiting miR-143 | Leading to proliferation and fibrosis of MCs | 115 |